Skip to content

Mini-Crush Or Controlled Balloon-Crush For True Coronary Bifurcation Lesions

Mini-Crush Or Controlled Balloon-Crush For True Coronary Bifurcation Lesions

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06880978
Enrollment
400
Registered
2025-03-18
Start date
2025-03-03
Completion date
2026-08-01
Last updated
2025-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Bifurcation Lesions, Death, Myocardial Infarction (MI), Stent Thrombosis, Stroke

Keywords

Coronary bifurcation, death, revascularization, stenting

Brief summary

The mini-crush technique is one of the leading 2-stent techniques frequently applied by interventional cardiologists to treat complex bifurcation lesions. In the last 20 years, many technical innovations and iterations of mini-crush technique have been developed, and it maintains its popularity among invasive cardiologists. Moreover, mini-crush and double kissing-crush techniques have been compared in terms of clinical results in both left main and non-left main coronary bifurcation patient populations and no significant difference was found. However, the most important challenges of the mini-crush technique are the rewiring and advancement of a 1:1 non-compliant side-branch balloon after the main branch stent has been implanted. These challenges usually necessitate the use of a low profile balloon or additional support maneuvers (such as anchor balloon). Recently, a novel modified mini-crush-crush technique (controlled balloon-crush) has been introduced to the literature and is one of the most up-to-date crush techniques. The main advantage of this technique over the contemporary mini-crush technique is that the side branch can be easily rewired and the 1:1 size non-compliant balloon can easily pass through the crushed stent structure in the ostial part of the side branch. The basic rationale of this is that the crushing of the side branch stent is done in a more controlled manner (by slowly deflation of the side branch stent balloon) and this causes less disruption of the stent cells. This prospective observational study aims to assess the procedural and 1-year clinical outcomes of the contemporary mini-crush and controlled balloon-crush (modified mini-crush) double stenting techniques in patients with true coronary bifurcation lesions.

Interventions

None listed

Sponsors

Istanbul Medipol University Hospital
CollaboratorOTHER
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital
CollaboratorOTHER
Başakşehir Çam & Sakura City Hospital
CollaboratorOTHER_GOV
Sisli Hamidiye Etfal Training and Research Hospital
CollaboratorOTHER
Ankara Etlik City Hospital
CollaboratorOTHER_GOV
Ankara City Hospital Bilkent
CollaboratorOTHER
Istanbul University - Cerrahpasa
CollaboratorOTHER
Trakya University
CollaboratorOTHER
Cigli Regional Training Hospital
CollaboratorOTHER
Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital
CollaboratorOTHER_GOV
İstanbul Bağcılar Training and Research Hospital
CollaboratorUNKNOWN
Istanbul Mehmet Akif Ersoy Educational and Training Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged \>18 * PCI with mini-crush or controlled balloon-crush * Complex coronary bifurcation lesion (Medina 0.1.1 and Medina 1.1.1)

Exclusion criteria

* Non-complex bifurcation anatomy * Bail-out 2-stent (reverse mini-crush or reverse controlled balloon-crush) * ST-elevation myocardial infarction * Cardiogenic shock status * In-stent restenosis * A history of coronary artery bypass grafting * Implantation of bare-metal stent * End-stage hepatic or renal disease * \<1-year life expectancy

Design outcomes

Primary

MeasureTime frameDescription
Major adverse cardiac events (MACE)12-monthsThe primary endpoint is defined as the composite of the rates of major adverse cardiac events (MACE) (%) including cardiac death (%), target vessel myocardial infarction (%), and target lesion revascularization (%).

Secondary

MeasureTime frameDescription
Major adverse cardiovascular and cerebral events (MACCE)12-monthsThe secondary endpoint (clinical) is defined as the composite of the rates of major adverse cardiac and cerebral events (MACCE) (%) including all-cause death (%), target vessel myocardial infarction (%), target lesion revascularization (%), probable or definite stent thrombosis (%), or stroke (%).

Countries

Turkey (Türkiye)

Contacts

Primary ContactFatih Uzun, Professor
fatihuzun28@gmail.com+90 5057705766
Backup ContactAhmet Güner, MD
ahmetguner488@gmail.com+90 2126922000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026